Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk - Wikidata - awgldk - TriplyDB

Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk

Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk

http://www.wikidata.org/entity/Q34345107

about

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications.Revisiting the role of antiandrogen strategies in ovarian cancer.Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studies Androgen receptor CAG repeats, non-random X chromosome inactivation, and loss of heterozygosity at Xq25 in relation to breast cancer risk Base excision repair: contribution to tumorigenesis and target in anticancer treatment paradigms Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.Sex steroid-related candidate genes in psychiatric disorders.The androgen receptor cytosine-adenine-guanine repeat length contributes to the development of epithelial ovarian cancer Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy.Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report.Menstrual pain and risk of epithelial ovarian cancer: results from the Ovarian Cancer Association Consortium.Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence.Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium.Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas.Inhibition of tumor cell growth by adenine is mediated by apoptosis induction and cell cycle S phase arrest.Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium.The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies.Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.

P2860

Q24619808-9634EEBA-75AE-48F9-8A28-FB91EC3EB7F0 Q28240630-71B19188-60C0-4A27-9AE4-580F8C422943 Q30252952-6E052470-323B-4ADE-B89A-AA18736F473F Q30275068-2C4B6585-EFE5-4102-91C6-64AD914FEB2F Q30276359-48B5D353-6E91-45C4-BCCD-35326D46489E Q30276610-E74BDC89-C110-4574-BD8F-5CB264E41D36 Q30276777-0743A08A-DDE6-453A-AB18-7331FA8A6B70 Q30277016-13B0C111-F58D-40A1-AAF0-3FDBC1472992 Q33710140-256D0300-5C0C-4B9A-A942-A3BE5CC41A8D Q34219464-F5F36241-72E3-49CE-8AF6-79687EE3B482 Q34338047-4D4DA0BC-451B-4BD8-AF58-2E21BE4EB57F Q34453715-20A658A7-F94E-4197-993E-F6A9A6C9332C Q34557167-CBFF31C8-B907-4769-B1AE-2695541CF497 Q34794017-008CAC06-225A-4C67-97CB-99E0BBC5879C Q34794065-7D599EBC-0BB7-41E2-86A6-840603E3DF61 Q35104856-01A55386-6D18-4F6D-B316-AF1768671676 Q35955906-F2A4805C-DE8B-404D-A5BB-61F3EBF84D3A Q36027025-4F63CAA9-D03B-461B-AAB3-0A03FD44A731 Q36737983-059AC19B-EF4E-46E9-82F1-202826F516A4 Q36739046-FF6191FB-57AC-4520-8394-1BD623AD0FC4 Q37071502-079653D5-007D-4353-B419-D41483C7859B Q37151786-F7503432-822A-449F-9FD0-A8833CD7D841 Q37153564-32B29A56-7182-4B21-8B00-6E40858D39F6 Q37185861-6D6D8B4A-D11D-44CA-AF59-767D312495DE Q37194644-5C64AABD-3F20-4784-B4CF-9B1F2047F7D1 Q37218434-E8D21E77-2015-4E14-8FBB-8B50EE4D1504 Q37282647-844CC7C5-54EF-4849-BA0F-963FEF72BA98 Q37378287-C88828F2-A7C5-46F6-ADE7-E702DD16025D Q37584843-608E23BC-C668-488C-9328-8784C220736B Q37681721-FE9F05B0-25B0-4AA8-97CC-615FB4CC94F7 Q38619748-98AA8677-C847-4E30-9398-BCC2F92ED1A0 Q38638265-1D3D4460-0136-4F44-8FDD-D1193D10BB7F Q38716934-3F3D49A5-EDAE-43FF-9B2A-52C46E48EE0F Q39326953-BEFAD393-AF30-480B-856B-E68F1DF0D715 Q40397279-E94B17B9-0B95-4CD9-898B-7509F870024B Q44819882-C337993F-B420-430C-AD69-7DD6065F2322 Q47109351-520A3B0D-B006-4E10-AAC1-348D0C52A97C Q47298863-E2ABABF7-C006-4C8B-82B6-937E5DBCDE2E Q50709318-91D75DE3-AEEE-4713-B857-4CA5D2929B76 Q52759419-A0CC9EB3-4144-4DAA-9132-6CC80486DC75

P2860

Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk

http://www.wikidata.org/entity/Q34345107

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Androgen receptor cytosine, ad ...... elation to ovarian cancer risk

@ast

Androgen receptor cytosine, ad ...... elation to ovarian cancer risk

@en

Androgen receptor cytosine, ad ...... elation to ovarian cancer risk

@nl

type

label

Androgen receptor cytosine, ad ...... elation to ovarian cancer risk

@ast

Androgen receptor cytosine, ad ...... elation to ovarian cancer risk

@en

Androgen receptor cytosine, ad ...... elation to ovarian cancer risk

@nl

prefLabel

Androgen receptor cytosine, ad ...... elation to ovarian cancer risk

@ast

Androgen receptor cytosine, ad ...... elation to ovarian cancer risk

@en

Androgen receptor cytosine, ad ...... elation to ovarian cancer risk

@nl

P1433

Q34345107-E23C500C-1879-42F7-973C-EB8360E3DA64

P1476

Q34345107-B29A76A8-2222-4F5C-B5D2-079933ED973C

P2093

Q34345107-1ED0CA8A-5E90-4085-9B3E-E06CFEAAA171

Q34345107-BE9C2072-A744-4366-8628-937BBAA8A746

Q34345107-C735B0B9-908F-446D-99B5-1B92D0265C27

Q34345107-CECD337A-14A7-4E25-8641-8AF871C1F8D0

Q34345107-D8281B47-942A-4339-B249-B3453D5D578F

P2860

Q34345107-06AE28B9-C0AB-4C6A-AEC7-3DF3C63681CF

Q34345107-14155966-5C49-4994-8444-200032BC8890

Q34345107-1B303A67-7337-4EE1-80E3-6AB2FEC7F2AE

Q34345107-1BA4C087-F280-4FB0-8E04-B42373E67C30

Q34345107-29D79BEC-941C-44CB-9CAA-280198ABC482

Q34345107-2D82E662-2BB3-4F17-9D5C-67969C0FD1F4

Q34345107-2DD089B9-792D-433A-B247-03A9A595C27D

Q34345107-2DF576D8-78A6-4278-A852-56E38B3C759C

Q34345107-35CEDE8D-2C23-47AD-AFBE-3A3D02317A55

Q34345107-3A4C8802-F5A6-4311-A88F-F9D7F805C92E

P304

Q34345107-F4D1E01C-C465-44BE-B856-C0D4B116D209

P31

Q34345107-F8D7BD27-9EBE-4B4A-9450-0E8C65A4BC57

P356

Q34345107-84F4007B-9E81-4128-9AEC-58417C11E2E4

P407

Q34345107-111BBBEF-BAE3-492A-AE79-155FB2BD6B5F

P433

Q34345107-B849C6D7-B206-41DD-862D-E1A464E00011

P478

Q34345107-67829D00-5931-47CF-8AC7-61BDC0458DB4

P577

Q34345107-3D4CB680-C6D4-437F-89F7-47581398222B

P698

Q34345107-337508B7-E6AA-4ACE-AE1B-32CBFDAF44C2

P921

Q34345107-25266AC0-1126-474C-B82A-CC375DBEA322

P932

Q34345107-C4912F08-D43D-403E-AB8E-3E6464B960C0

P356

0008-5472.CAN-04-3885

P1433

Cancer Research

P1476

Androgen receptor cytosine, ad ...... elation to ovarian cancer risk

@en

P2093

Daniel W Cramer

http://www.w3.org/2001/XMLSchema#string

Immaculata De Vivo

http://www.w3.org/2001/XMLSchema#string

Kathryn L Terry

http://www.w3.org/2001/XMLSchema#string

Linda Titus-Ernstoff

http://www.w3.org/2001/XMLSchema#string

Mei-Chiung Shih

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in the progesterone receptor gene and ovarian cancer risk.

The structure of haplotype blocks in the human genome

The future of genetic studies of complex human diseases

Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population

Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study.

Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length.

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.

Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues.

The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.

Epithelial ovarian cancer risk among women with polycystic ovary syndrome.

P304

5974-5981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-04-3885

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15994977

http://www.w3.org/2001/XMLSchema#string

P921

P932

1364476

http://www.w3.org/2001/XMLSchema#string